ArticleJournal of the American Heart Association2026
Association Between Calcium Supplementation and Recurrence of Cardiovascular Events in Patients With Cardiovascular Disease: A Population-Based Cohort Study.
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe cardiovascular safety of calcium supplements in individuals with major cardiovascular disease (CVD) remains unclear. This study investigated the association between calcium supplementation and the risk of CVD recurrence in patients with established CVD.
methodsA retrospective population-based study was conducted in Hong Kong of individuals aged ≥40 years newly diagnosed with CVD from January 1, 2006, to December 31, 2015. The treatment group consisted of patients with CVD prescribed calcium supplements, while the control group consisted of those who never prescribed calcium supplements from January 1, 2005, to December 31, 2020. Propensity score matching and Cox proportional hazard models were adopted to balance the baseline characteristics and estimate hazards ratios (HRs) for CVD recurrence.
resultsThe matched cohort included 17 720 patients with CVD in each arm. Calcium supplementation was associated with an increased risk of recurrence of adverse CVD events (HR, 1.10 [95% CI, 1.07-1.14]) and CVD-related hospitalization or accident and emergency department attendance (HR, 1.16 [95% CI, 1.13-1.20]). Calcium-only supplementation had higher CVD recurrence risk (HR, 1.21 [95% CI, 1.17-1.25]) than the combination of vitamin D (HR, 0.97 [95% CI, 0.93-1.01]), and a more pronounced association was observed in men (HR, 1.15 [95% CI, 1.09-1.20]) than women (HR, 1.07 [95% CI, 1.03-1.11]).
conclusionsIn patients with major CVD, calcium supplementation is associated with an increased risk of CVD recurrence, particularly with calcium-only use and in men. Caution should be exercised when prescribing or using calcium supplements among patients with CVD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.